Anthony Doyle is a seasoned finance executive with extensive experience in the biotechnology and clinical trial industries. Currently serving as the Chief Financial Officer at Flourish Research since April 2025, Anthony previously held the CFO position at BioCryst Pharmaceuticals from April 2020 to April 2025 and at Worldwide Clinical Trials from January 2015 to April 2020. Prior experience includes CFO at World Book, a Berkshire Hathaway company, and roles at GE Healthcare where Anthony contributed as Global Finance Manager and Risk, Pricing and Portfolio Leader. Anthony began the career journey with General Electric in corporate audit and financial management roles. Anthony holds a Graduate Certificate in Corporate Treasury and a BA in European Business & French from Dublin City University.
This person is not in any teams
This person is not in any offices